Reports for TENOFOVIR DISOPROXIL FUMARATE

Ingredient

TENOFOVIR DISOPROXIL FUMARATE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-04-03 2019-04-23 80423
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-04-23 2019-06-26 82201
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-07-03 2019-07-10 88291
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-07-29 2019-09-26 90113
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Avoided shortage 2020-05-06 2020-05-12 114152
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2017-09-27 2017-10-02 23663
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2018-03-05 2018-03-20 41868
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-04-04 2019-05-21 80530
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-07-12 2019-08-17 89158
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-09-04 2019-09-06 92974

Showing 11 to 20 of 41

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1